This brand name is authorized in Nigeria.
The drug EXPEZOL contains one active pharmaceutical ingredient (API):
1
|
UNII
F4216019LN - ALBENDAZOLE
|
Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
A4-4983 | Tablet | EXPEZOL TABLET 200mg TAB 200 mg 12 | EXPEZOL TABLET 200mg ALBENDAZOLE 200mg Albendazole 200mg Magnesium Stearate 3mg Maize Starch 98mg Purified Talk 6mg Colloidal Anhydrous Silica 3mg Sodium Starch Glycollate 10mg Croscarmellose Sodium 10mg Purified Water 0.0768ml A4-4983 Drugs Imported Products 12 Prescription Only Medicine (POM) 18/01/2022 SWISS PHARMA NIGERIA LIMITED, , DOPEMU ROAD, IKEJA LAGOS 17745276 swipha@swiphanigeria.com Vapi Care Pharma Pvt Ltd, plot No 225/3 GIDC Vapi 396- 195, Gujarat India , India | 26/04/2023 |
A4-4984 | Suspension | EXPEZOL SUSPENSION SUSP 200 mg/5 mL 1 x 10ml | EXPEZOL SUSPENSION ALBENDAZOLE SUSPENSION Albendazole 200 mg/5ml Polysorbate-80 2.000 mg Glycerin 60.00 mg Sorbitol 70% 200.0 mg Propylene glycol 15.00 mg Sugar (Sucrose) 500.0 mg Methyl hydroxybenzoate 1.501 mg Propyl hydroxybenzoate 0.149 mg Carmellose Sodium 2.000mg Colloidal Anhydrous Silica 4.000 mg Flavour raspberry 1.000 mg Citric Acid Monohydrate 1.941 mg Purified Water Q.S. A4-4984 Drugs Imported Products 1 x 10ml Over The Counter (OTC) 20/03/2023 SWISS PHARMA NIGERIA LIMITED, , DOPEMU ROAD, IKEJA LAGOS 17745276 swipha@swiphanigeria.com VAPI CARE PHARMA PVT LTD- 396-195, VAPI CARE PHARMA PVT LTD., Plot No 225/3, G.I.D.C, Near Morarji Circle, Vapi -396-195, Gujarat, INDIA , India | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
P02CA03 | Albendazole | P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A4-4983, A4-4984 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.